Renosen Pharmaceuticals Private Limited

This profile gathers the share dealings of Renosen Pharmaceuticals Private Limited in Senores Pharmaceuticals Limited. We count 10 filings; the first trade dates from 27 January 2025 and the latest from 28 March 2026.

Purchases make up the whole of the open-market record (7 purchases, €163k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and no sales.

The median purchase comes to €21k. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 1 April 2026: a transaction of €5.5M, in Senores Pharmaceuticals Limited. The most recent open-market purchase was published on 1 January 2026, 296 days ago. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 1 day. That lag is the time during which only the insider knows about the trade. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.